These data are in agreement with the concept that BDNF is effective as an AD therapeutic agent, which has been extensively examined using small molecular TrkB agonists, including 7,8-dihydroxyflavone by recent studies42, 43, 44. Here, NTRK2 is linked to Alzheimer disease.